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Continuing aortic neck dilatation, most probably an expression of ongoing aneurysmal wall degeneration of the
infrarenal aortic segment, has been shown to seriously impair clinical results after endovascular abdominal aortic
aneurysm repair. However, conflicting data on the extent and clinical relevance on this observation have recently been
published. This article reviews the recent literature, summarizing our current understanding of the role of aortic neck
dilatation after open surgical and endovascular abdominal aortic aneurysm repair. In addition, differences in methodol-
ogy of studies on aortic neck dilatation are highlighted. (J Vasc Surg 2008;47:886-92.)Endovascular aortic repair (EVAR) of abdominal aortic
aneurysms (AAA) was introduced in the early 1990s1 and
was shown to be associated with significant advantages
compared with open surgical AAA repair (OAR) in the
perioperative period related to the minimal invasiveness of
the procedure.2,3 Certain intrinsic sequelae such as en-
doleaks and graft migration, however, were shown to seri-
ously hamper the long-term durability of this treatment
option.4-8
Clinical routine reveals a wide spectrum of AAA mor-
phologies with varying extent of aneurysmal degeneration
at different levels of the infrarenal aorta.9 Amacroscopically
thrombus-free, nondilated vascular portion is present dis-
tally to the renal arteries in a substantial subset of patients.9
This segment, often referred to as the infrarenal aortic neck,
is generally used as a graft attachment site for OAR as well
as EVAR.
The clinical significance of continuing aortic neck dila-
tation (AND) is the subject of ongoing discussion. AND
was reported to occur in up to 43% of patients after
OAR,10-14 whereas the incidence of false aneurysm forma-
tion is 1.3% to 3% during long-term follow-up.15-18 This
observationmight be due to the presence of sutures directly
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886attaching the vascular graft to the aortic wall, thereby
preventing graft migration. On the other hand, it might be
related to the fact that imaging surveillance was not per-
formed to the same extent as after EVAR in studies assess-
ing OAR, thereby potentially underestimating the true
incidence of AND,15-18
In contrast, AND was reported in up to 28% of
patients at 2 years and in 59% at 4 years,19-30 and was
shown to be associated with adverse mid-term outcomes
after EVAR.19,22,30 Other authors have not observed any
significant AND or AND-related problems after
EVAR.31-34
Continuing expansion of aortic necks poses a substan-
tial threat to the mid- and long-term durability of EVAR
because proximal fixation is jeopardized once the diameter
of the neck exceeds that of the endograft. Given that the
average life expectancy of a 65-year-old person in the
United States today is 18 years,35 and considering that
the application of EVAR to even younger low-risk patients
is the subject of ongoing discussion,36-38 long-term dura-
bility of EVAR is of utmost importance. At present, from a
classical surgical standpoint, EVAR has to be regarded as a
palliative treatment approach until dedicated means to
prevent AND and graft migration have been identified and
tested in a clinical setting.
Recent evidence from laboratory investigations39 and
epidemiologic studies40,41 indicate that drug treatment
might play a key role in patients with AAA in the near future
and might have the potential to prevent or slow the process
of AND.
Purpose of the present review is to summarize current
evidence on infrarenal AND after OAR and EVAR.
aging
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DILATATION IN PATIENTS WITH
ABDOMINAL AORTIC ANEURYSM
Ample evidence documents continuing dilatation of
the infrarenal aortic segment in healthy persons as a conse-
quence of ageing,42-44 and hence, in small AAAs45 as well
as in patients undergoing OAR10-14 or EVAR.19,22-30,46,47
More important, AND was shown to be associated with
graft migration in up to 35.3% of patients22 and was iden-
tified as a predictor of late type I endoleaks30 and repeat
intervention.19
Although several studies have assessed growth rates of
AAA during its natural course, information on changes in
AAA neck morphology over time, especially on the longi-
tudinal extent of the AAA neck, are scarce. After following
up 54 patients with AAA diameters of 4 to 5.4 cm for 2
years, Yau et al45 described a significant increase in diameter
and tortuosity of the aortic neck along with a substantial
decrease in the longitudinal extent of this nonaneurysmal
aortic segment. These important data indicate that the
natural history of AAA includes a gradual but substantial
involvement of the infrarenal aortic neck, with aneurysmal
degeneration continuing from the level of the AAA sac as
AAA growth progresses. Hence, these findings support the
hypothesis that an ongoing aneurysmal degeneration plays
a key role in the etiology of AND.
Several authors investigated changes in infrarenal aortic
neck dimensions after OAR (Table I).10-14 Increases in
infrarenal aortic neck diameter were described to be as high
as 0.57 mm/y.11-14 Relevant AND was found in 43% of
patients after 42 months, if defined as an overall increase in
diameter of 5 mm.10
After EVAR, yearly increases in infrarenal aortic neck
diameter of up to 0.99  1.1 mm and 2.03  12.6 mm
were found in patients with formerly asymptomatic or
ruptured AAA, respectively23 (Table II).20-30 When com-
puted tomography (CT) was used to assess cross-sectional
neck surface area, maximum neck enlargement was de-
scribed to be as high as 15.5% at 1 year21 and 36% at 3
years.29 AND was found in up to 28% of EVAR patients at
Table I. Summary of studies reporting neck dilatation in p
repair
First author No.
Neck
measurement
specifications AND definition
Lipski10 373 Translumbar
aortography*†
5-mm diameter incr
Falkensammer11 52 CT†‡ Absolute change, m
Liapis12 100 DUS*† Absolute change, m
Sonesson13 64 CT*† Absolute change, m
Illig14 346 CT*† Absolute change, m
AND, Aortic neck dilatation; NS, not specified; CT, computed tomograph
*Measurement results based on comparison of preoperative vs follow-up im
†Measurement results not based on life-table or Kaplan-Meier analysis.
‡Measurement results based on comparison of postoperative vs follow-up im2 years and in 59% at 4 years when defined as an increase inneck diameter of 4 mm.19 Correspondingly, when a
relative change of at least 15% in neck diameter was applied
as basis for discrimination, AND was reported in 24.9% of
patients at 2 years and in 35.1% at 4 years.24 At present, the
structural reaction of the aortic wall to the presence of an
endograft is unclear. Although two groups26,48 blamed
stent graft oversizing as a potential mechanical reason for
AND,26,48 others did not confirm this finding.20,21,28
The incidence of AND has recently been related to
proximal neck and maximum AAA diameters at baseline,19
whereas AAA size was shown to directly correlate with
inflammatory markers such as interleukin-6 and C-reactive
protein.49-52 Levels of matrix metalloproteinases-8 and9
as well as increased medial neovascularization and overex-
pression of proangiogenic cytokines were also shown to be
increased at the site of AAA rupture.53,54 Of interest was
that para-anastomotic aneurysms were shown to occur at
significantly higher frequencies after surgical repair of rup-
tured than of nonruptured AAAs,55 thereby corroborating
findings in patients undergoing EVAR.23 Considering
these findings, an increase in inflammatory activity in the
infrarenal aortic segment might be responsible for AND in
a substantial subset of patients.
STUDIES REPORTING ABSENCE OF AORTIC
NECK DILATATION
Various authors did not find evidence for AND after
EVAR (Table III).31-34 May et al31 published long-term
follow-up of EVAR patients in whom self- and balloon-
expandable endografts had been deployed. At 7 years, that
series revealed a probability of AND of only 5.7% in 15
patients at risk.31
Of interest was that two series found that the use of
balloon-expandable endografts protected from AND.32,33
Parodi and Ferreira33 retrospectively analyzed long-term
follow-up of 30 patients undergoing EVAR using a cus-
tom-made balloon-expandable device and did not find
significant AND. In that article, however, the method of
AND quantification was not specified. Malas et al32 pub-
lished a retrospective series of 77 patients undergoing
nts undergoing open surgical abdominal aortic aneurysm
Follow-up Outcome
Clinical
impact of
AND
Mean 42 months. 43% of patients at 42 mon NS
Mean 44 months. 0.16 mm/y NS
Mean 4.7 years. 0.57 mm/y None
Mean 71 months. 0.48 mm/y NS
Mean 89 months. 4.3 mm increase at 89 months NS
S, duplex ultrasound.
data.
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neither find AND nor graft migration after 31 months of
follow-up.
In both of these series,32,33 the number of patients at
risk was reduced to 50% during follow-up, thereby leading
Table II. Summary of studies reporting neck dilatation in
repair
First author N
Neck measurement
specifications
Definition of
AND Follo
Sampaio20 144 CT*† Relative
diameter
increase, 10%-
15%
Media
day
(An
629
(An
Wever21 33 CT‡§ Absolute
change, %
surface area
Media
mo
Napoli22 90 CT and DUS‡§ 2.5-mm
diameter
increase
Mean
mo
Badger23 161 CT ‡§ Absolute
change, mm
Up to
yea
Diehm24 6383 CT*† Relative change,
15%
diameter
increase
Mean
mo
Cao19 230 CT†‡ 4 mm diameter
increase
Media
mo
Sonesson25 34 CT*§ Absolute
change, mm
Mean
mo
Badran26 73 CT*§ Relative change,
% diameter,
mm
Mean
mo
Matsumura27 59 CT‡§ Absolute
change, mm
Mean
mo
Makaroun28 314 CT‡§ 2.5-mm
diameter
increase
Up to
yea
Prinssen29 37 CT‡§ Relative change,
% surface area
Up to
yea
Dillavou30 729 CT‡§ 3-mm diameter
increase
Up to
yea
AAA, Abdominal aortic aneurysm;AND, aortic neck dilatation, EVAR, end
SXS, self-expandable stent graft; CT, computed tomography; DUS, duplex
aMedtronic, Minneapolis, Minnesota.
bGuidant, Indianapolis, Indiana
*Measurement results based on comparison of preoperative vs follow-up im
†Measurement results based on cumulative analysis (life-table or Kaplan-Me
‡Measurement results based on comparison of first postoperative vs follow-
§Measurement results not based on life-table or Kaplan-Meier analysis.to a potential selection bias towards underestimation ofAND, especially since one series33 excluded acute and
mid-term failures from long-term analysis. These observa-
tions led to speculation that the radial expansion force
exerted by the stent graft would increase the tendency
towards myointimal hyperplasia in the aortic neck, thereby
nts undergoing endovascular abdominal aortic aneurysm
Graft type Quantification of AND Clinical impact of AND
7
),a
b
100% SXS 10% increase at 2 years
in 36.1% (AneuRx)
and in 23.5%
(Ancure); 15%
increase at 2 years in
12.4% (AneuRx) and
in 9.1% (Ancure)
Patients with graft
migration had higher
mean percentages of
AND at 1.5 years
(p0.012).
100% SXS 10.3% surface area
increase at 6 months;
15.5% surface area
increase at 1 year
No correlation with
early or late endoleak.
1.1% BES;
98.9%
SXS
Cumulative incidence:
21.8%; 13% at 1
year; 33% at 2 years
35.3% of patients with
AND had distal
migration.
100% SXS For EVAR: 0.99  1.1
mm/y at 2 years for
asymptomatic; 2.61
 3.3 mm/y at 2
years for those
treated for rupture
Graft migrations were
associated with AND
in asymptomatic
patients as well as in
patients with
ruptured AAA.
3% BES;
97%
SXS
24.9% of patients at 2
years; 35.1% of
patients at 4 years
n/s
100% SXS 28% of patients at 2
years; 59% of
patients at 4 years
Late repeat intervention
associated with AND
(p0.0001).
100% SXS 1.65-mm increase at
25 months
n/s
4% BES;
96%
SXS
8.6% increase at 2
years, 10.3% increase
at 4 years
n/s
100% SXS 0.7  2.1mm/y n/s
100% SXS 13% after 1 year, 21%
after 2, 19% after 3
Migration in 1 patient
associated with AND.
100% SXS 20% surface area
increase at 2 years;
36% surface area
increase at 3 years
n/s
4.3% BES;
95.7%
SXS
AND in 20% of
patients after 2 years
AND significantly
influenced incidence
of late type I
endoleaks
(p0.001).
lar aneurysm repair;NS, not specified; BES, balloon-expandable stent graft;
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data.
aging data.1patie
w-up
n 25
s
euRx
days
cure)
n 12
nths
15
nths
2
rs
21
nths
n 24
nths
25
nths
26
nths
27
nths
3
rs
3
rs
5
rs
ovascu
ultras
aging
ier).1leading to a stabilization of the proximal graft fixation
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tic stent placement for occlusive disease,56,57 we do not
recommend to rely on a potential induction of restenosis to
enhance proximal graft fixation after EVAR.
Moreover, the hypothesis that graft design might have
a relevant influence on the incidence of AND is weakened
by the following finding: in a large group of patients from
the European Collaborators on Stent/Graft Techniques
for Aortic Aneurysm Repair (EUROSTAR) registry, even
suprarenal fixation and fixation with hooks did not prevent
AND.58 Thus, these data support the hypothesis that con-
tinuing AND is rather a perpetuation of the aneurysmal
disease process than related to specific interactions of dif-
ferent types of endografts with the aortic wall.
HETEROGENEITY OF STUDIES ON AORTIC
NECK DILITATION
Various potential reasons for the observed variation in
the incidence and extent of AND must be acknowledged.
The Society of Vascular Surgery/International Society of
Vascular Surgery reporting standards were published to
ensure uniform reporting with regard to clinical and mor-
phologic outcomes after EVAR.59 This consensus docu-
ment proposes two core requirements for AAA neck mea-
surements59:
● “Changes in aneurysm size should be referenced to
those measurements obtained from the first set of post-
operative images,” and
● “Life table or Kaplan-Meier analysis should be used to
analyze freedom from neck enlargement.”
Notably, compliance with these reporting standards
was poor, and several further problems with the presently
Table III. Summary of studies reporting absence of releva
abdominal aortic aneurysm repair
First
author No.
Neck
measurement
specifications AND definition Follow-up
Malas32 77 CT*† 2.5-mm diameter
increase
Mean 31 mon
Walker34 112 CT†‡ Absolute change,
mm
Up to 4 years
Parodi33 30 CT§ NS Mean 5 yea
May31 61 CT* 3-mm diameter
increase
Up to 9 years
AND, Aortic neck dilatation; NS, not specified; NA, not applicable; BES,
tomography, DUS, duplex ultrasound.
*Measurement results based on comparison of first postoperative vs follow-
†Measurement results not based on life-table or Kaplan-Meier analysis.
‡Measurement results based on comparison of preoperative vs follow-up im
§Measurement method and statistical analysis not specified.
Measurement results based on life-table or Kaplan-Meier analysis.1available studies on AND have to be addressed.First, four of five studies (80%) describing AND in
patients after OAR10,12-14 and six of 16 studies (38%)
analyzing neck morphology after EVAR compared the
preoperative neck diameter with follow-up measurements,
thereby not conforming to SVS/ISCVS reporting stan-
dards59 and potentially biasing findings by not considering
the impact of graft sizing during AAA repair.10,12-14
Second, five of five studies (100%) describing AND in
patients after OAR and 12 of 16 studies (75%) assessing
neck morphology after EVAR used statistical analyses other
than life-table or Kaplan-Meier methods.59 Thus, only two
of 16 studies (12.5%) assessing AND after EVAR19,31,59
fully met the core requirements of the SVS/ISCVS report-
ing standards.19,31,59
Third, substantial differences in the methodology for
the site at which the neck was measured have to be noted.
Notably, four of 16 studies (25%)19,20,27,30 defined the
level of measurement in relation to the proximal stent of the
endograft, thereby substantially biasing follow-upmeasure-
ments in patients with device migration. Moreover, the
segment referred to as the “infrarenal aortic neck” substan-
tially differed from being defined as the segment stretching
out from directly below the lowermost renal ar-
tery,11,12,23,28 to 3 mm,24 7.5 mm,26 or 1 cm60 distally to
the lowermost renal artery. Other definitions of the aortic
neck included the first CT section that contained at least
half of the proximal portion of the endograft19 or the CT
slice at mid-distance between lowermost renal artery and
the cranial extremity of the AAA sac.20
Thus, considering a progressive aneurysmal AAA neck
degeneration from distal to proximal, as described by Yau et
al,45 studies describing changes of the aortic neck diameter
only by measurements of the cranial segments of the prox-
eck dilatation in patients undergoing endovascular
Graft type AND quantification Clinical impact of AND
100% BES No AND and graft
migration in 41/77
patients at 31 months
None
NA No significant increase in
diameter
NS
100% BES No AND, 1 proximal
endoleak.
None
23% BES;
77%
SXS
94.3% probability of no
neck enlargement after
7 years
3 patients needed
endovascular
reintervention due to
graft migration
n-expandable stent graft; SXS, self-expandable stent graft; CT, computed
aging data.1
data.nt n
ths
rs
balloo
up im
agingimal neck11,12,23,24,26,28 would hence most likely underes-
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of these mentioned studies dedicatedly assessed changes in
the longitudinal extent of the aortic neck, thereby limiting
current evidence on AND to two-dimensional data.
It has to be kept in mind that the secure attachment of
endografts does not only rely on the fixation at the most
proximal segment of the neckbut rather on the full integrity of
the proximal landing zone. Unfortunately however, current
SVS/ISCVS recommendations do not contain a uniform
consensus definition on how to report the longitudinal extent
of the infrarenal neck.59 We have recently shown that dedi-
cated AAA neck volumetry can be performed with satisfying
intraobserver agreement provided that the precise longitudi-
nal extent of the neck is prespecified.61 Thus, we recommend
adapting this technique for future studies assessing the AND
to capture all dimensions of the infrarenal neck.
Fourth, significant differences in numbers of patients
studied as well as duration of follow-up within various
studies have to be acknowledged, especially because studies
that reported an absence of AND had only comparatively
small numbers of patients.31,33 Their reliability to exclude
the occurrence of AND during long-term follow-up is
therefore limited.
Fifth, and possibly most important, none of the pres-
ently available series on AND specify medical treatment and
adherence to smoking cessation, although cigarette smok-
ing has been identified as one of the main contributors to
AAA development and expansion.62-64 In addition, widely
available drugs such as angiotensin-converting enzyme in-
hibitors have been reported to prevent AAA progres-
sion.40,41 Their potential impact on the prevention of AND
therefore remains to be determined.
In summary, despite the study design limitations that
have been described, the evidence supporting a significant
incidence of AND during mid-term follow-up after EVAR
to date clearly outweighs the evidence against it. Although
no direct data for ongoing aneurysmal degeneration as a
major contributor to AND are presently available, indirect
evidence supports this hypothesis.
CONCLUSION
Current evidence on AND raises serious concerns
about long-term durability of stent graft fixation in the
proximal aortic neck despite a significant heterogeneity in
measurement methods and definitions of AND. Further
research needs to investigate the pathobiologic background
of AND and the impact of potential treatment concepts
targeted at its prevention. To enhance comparability of
future studies and to allow for three-dimensional neck
assessment, compliance with the reporting standards pro-
posed by the SVS/ISCVS 59 as well as three-dimensional
assessment of neck morphology over time using dedicated
AAA neck volumetry is warranted.59
AUTHOR CONTRIBUTIONS
Conception and design: ND, JS, IB
Analysis and interpretation: ND, FD
Data collection: NDWriting the article: ND, FD, JS, CK, IB
Critical revision of the article: ND, FD, BK, JS, CK, IB
Final approval of the article: ND, FD, IB
Statistical analysis: Not applicable
Obtained funding: Not applicable
Overall responsibility: ND
REFERENCES
1. Parodi JC, Palmaz JC, Barone HD. Transfemoral intraluminal graft
implantation for abdominal aortic aneurysms. Ann Vasc Surg 1991;5:
491-9.
2. Greenhalgh RM, Brown LC, Kwong GP, Powell JT, Thompson SG.
Comparison of endovascular aneurysm repair with open repair in pa-
tients with abdominal aortic aneurysm (EVAR trial 1), 30-day operative
mortality results: randomised controlled trial. Lancet 2004;364:843-8.
3. Prinssen M, Verhoeven EL, Buth J, Cuypers PW, van Sambeek MR,
Balm R, et al. A randomized trial comparing conventional and endovas-
cular repair of abdominal aortic aneurysms. N Engl J Med 2004;351:
1607-18.
4. Le Bas JF. Endovascular aneurysm repair versus open repair in patients
with abdominal aortic aneurysm (EVAR trial 1): randomised controlled
trial. Lancet 2005;365:2179-86.
5. Blankensteijn JD, de Jong SE, Prinssen M, van der Ham AC, Buth J, van
Sterkenburg SM, et al. Two-year outcomes after conventional or endovascular
repair of abdominal aortic aneurysms. N Engl JMed 2005;352:2398-405.
6. Zarins CK, White RA, Hodgson KJ, Schwarten D, Fogarty TJ. En-
doleak as a predictor of outcome after endovascular aneurysm repair:
AneuRx multicenter clinical trial. J Vasc Surg 2000;32:90-107.
7. Harris PL, Vallabhaneni SR, Desgranges P, Becquemin JP, van Mar-
rewijk C, Laheij RJ. Incidence and risk factors of late rupture, conver-
sion, and death after endovascular repair of infrarenal aortic aneurysms:
the EUROSTAR experience. European Collaborators on Stent/graft
Techniques for Aortic Aneurysm Repair. J Vasc Surg 2000;32:739-49.
8. Hobo R, Buth J. Secondary interventions following endovascular ab-
dominal aortic aneurysm repair using current endografts. A EURO-
STAR report. J Vasc Surg 2006;43:896-902.
9. Schumacher H, Eckstein HH, Kallinowski F, Allenberg JR. Morphom-
etry and classification in abdominal aortic aneurysms: patient selection
for endovascular and open surgery. J Endovasc Surg 1997;4:39-44.
10. Lipski DA, Ernst CB. Natural history of the residual infrarenal aorta after
infrarenal abdominal aortic aneurysm repair. J Vasc Surg 1998;27:805-11.
11. Falkensammer J, OldenburgWA, BieblM,Hugl B, Hakaim AG, Crook
JE, et al. Abdominal aortic aneurysm neck remodeling after open
aneurysm repair. J Vasc Surg 2007;45:900-5.
12. Liapis C, Kakisis J, Kaperonis E, Papavassiliou V, Karousos D, Tzonou A,
et al. Changes of the infrarenal aortic segment after conventional abdom-
inal aortic aneurysm repair. Eur J Vasc Endovasc Surg 2000;19:643-7.
13. Sonesson B, Resch T, Lanne T, Ivancev K. The fate of the infrarenal
aortic neck after open aneurysm surgery. J Vasc Surg 1998;28:889-94.
14. Illig KA, Green RM, Ouriel K, Riggs P, Bartos S, DeWeese JA. Fate of
the proximal aortic cuff: implications for endovascular aneurysm repair.
J Vasc Surg 1997;26:492-9; discussion 499-501.
15. Biancari F, Ylonen K, Anttila V, Juvonen J, Romsi P, Satta J, et al.
Durability of open repair of infrarenal abdominal aortic aneurysm: a
15-year follow-up study. J Vasc Surg 2002;35:87-93.
16. Crawford ES, Saleh SA, Babb JW 3rd, Glaeser DH, Vaccaro PS, Silvers
A. Infrarenal abdominal aortic aneurysm: factors influencing survival
after operation performed over a 25-year period. Ann Surg 1981;193:
699-709.
17. Plate G, Hollier LA, O’Brien P, Pairolero PC, Cherry KJ, Kazmier FJ.
Recurrent aneurysms and late vascular complications following repair of
abdominal aortic aneurysms. Arch Surg 1985;120:590-4.
18. Hallett JW Jr, Marshall DM, Petterson TM, Gray DT, Bower TC,
Cherry KJ Jr, et al. Graft-related complications after abdominal aortic
aneurysm repair: reassurance from a 36-year population-based experi-
ence. J Vasc Surg 1997;25:277-84; discussion 285-6.
19. Cao P, Verzini F, Parlani G, Rango PD, Parente B, Giordano G, et al.
Predictive factors and clinical consequences of proximal aortic neck
JOURNAL OF VASCULAR SURGERY
Volume 47, Number 4 Diehm et al 891dilatation in 230 patients undergoing abdominal aorta aneurysm repair
with self-expandable stent-grafts. J Vasc Surg 2003;37:1200-5.
20. Sampaio SM, Panneton JM, Mozes G, Andrews JC, Noel AA, Kalra M,
et al. Aortic neck dilation after endovascular abdominal aortic aneurysm
repair: should oversizing be blamed? Ann Vasc Surg 2006;20:338-45.
21. Wever JJ, de Nie AJ, Blankensteijn JD, Broeders IA, Mali WP, Eikel-
boom BC. Dilatation of the proximal neck of infrarenal aortic aneu-
rysms after endovascular AAA repair. Eur J Vasc Endovasc Surg 2000;
19:197-201.
22. Napoli V, Sardella SG, Bargellini I, Petruzzi P, Cioni R, Vignali C, et al.
Evaluation of the proximal aortic neck enlargement following endovas-
cular repair of abdominal aortic aneurysm: 3-years experience. Eur
Radiol 2003;13:1962-71.
23. Badger SA, O’Donnell M E, Makar RR, Loan W, Lee B, Soong CV.
Aortic necks of ruptured abdominal aneurysms dilate more than asymp-
tomatic aneurysms after endovascular repair. J Vasc Surg 2006;44:
244-9.
24. Diehm N, Hobo R, Baumgartner I, Do DD, Keo HH, Kalka C, et al.
Influence of pulmonary status and diabetes mellitus on aortic neck
dilatation following endovascular repair of abdominal aortic aneurysms:
a eurostar report. J Endovasc Ther 2007;14:122-9.
25. Sonesson B, Malina M, Ivancev K, Lindh M, Lindblad B, Brunkwall J.
Dilatation of the infrarenal aneurysm neck after endovascular exclusion
of abdominal aortic aneurysm. J Endovasc Surg 1998;5:195-200.
26. Badran MF, Gould DA, Raza I, McWilliams RG, Brown O, Harris PL,
et al. Aneurysm neck diameter after endovascular repair of abdominal
aortic aneurysms. J Vasc Interv Radiol 2002;13:887-92.
27. Matsumura JS, Chaikof EL. Continued expansion of aortic necks after
endovascular repair of abdominal aortic aneurysms. EVT Investigators.
EndoVascular Technologies, Inc. J Vasc Surg 1998;28:422-30; discus-
sion 430-1.
28. Makaroun MS, Deaton DH. Is proximal aortic neck dilatation after
endovascular aneurysm exclusion a cause for concern? J Vasc Surg
2001;33:S39-45.
29. Prinssen M, Wever JJ, Mali WP, Eikelboom BC, Blankensteijn JD.
Concerns for the durability of the proximal abdominal aortic aneurysm
endograft fixation from a 2-year and 3-year longitudinal computed
tomography angiography study. J Vasc Surg 2001;33:S64-9.
30. Dillavou ED, Muluk S, Makaroun MS. Is neck dilatation after endovas-
cular aneurysm repair graft dependent? Results of 4 US Phase II trials.
Vasc Endovasc Surg 2005;39:47-54.
31. May J, White GH, Ly CN, Jones MA, Harris JP. Endoluminal repair of
abdominal aortic aneurysm prevents enlargement of the proximal neck:
a 9-year life-table and 5-year longitudinal study. J Vasc Surg 2003;37:
86-90.
32. Malas MB, Ohki T, Veith FJ, Chen T, Lipsitz EC, Shah AR, et al.
Absence of proximal neck dilatation and graft migration after endovas-
cular aneurysm repair with balloon-expandable stent-based endografts.
J Vasc Surg 2005;42:639-44.
33. Parodi JC, Ferreira LM. Ten-year experience with endovascular therapy
in aortic aneurysms. J Am Coll Surg 2002;194:S58-66.
34. Walker SR, Macierewicz J, Elmarasy NM, Gregson RH, Whitaker SC,
Hopkinson BR. A prospective study to assess changes in proximal aortic
neck dimensions after endovascular repair of abdominal aortic aneu-
rysms. J Vasc Surg 1999;29:625-30.
35. Centers for Disease Control and Prevention. United States life tables.
Available at: http://www.cdc.gov/nchs/datawh/statab/unpubd/
mortabs/lewk3_10.htm.
36. Ouriel K, Srivastava SD, Sarac TP, O’Hara P J, Lyden SP, Greenberg
RK, et al. Disparate outcome after endovascular treatment of small
versus large abdominal aortic aneurysm. J Vasc Surg 2003;37:1206-12.
37. Cao P. Comparison of surveillance vs Aortic Endografting for Small
Aneurysm Repair (CAESAR) trial: study design and progress. Eur J
Vasc Endovasc Surg 2005;30:245-51.
38. Ouriel K. Treating smaller AAAs. Does the availability of endovascular
grafts change the size threshold for repair? Endovasc Today 2005;3:39-
42.
39. Yoshimura K, Aoki H, Ikeda Y, Fujii K, Akiyama N, Furutani A, et al.
Regression of abdominal aortic aneurysm by inhibition of c-Jun N-
terminal kinase. Nat Med 2005;11:1330-8.40. Hackam DG, Thiruchelvam D, Redelmeier DA. Angiotensin-convert-
ing enzyme inhibitors and aortic rupture: a population-based case-
control study. Lancet 2006;368:659-65.
41. Diehm N, Baumgartner I. ACE inhibitors and abdominal aortic aneu-
rysm. Lancet 2006;368:622-3.
42. Sonesson B, Lanne T, Hansen F, Sandgren T. Infrarenal aortic diameter
in the healthy person. Eur J Vasc Surg 1994;8:89-95.
43. Lederle FA, Johnson GR, Wilson SE, Gordon IL, Chute EP, Littooy
FN, et al. Relationship of age, gender, race, and body size to infrarenal
aortic diameter. The Aneurysm Detection and Management (ADAM)
Veterans Affairs Cooperative Study Investigators. J Vasc Surg 1997;26:
595-601.
44. Pearce WH, Slaughter MS, LeMaire S, Salyapongse AN, Feinglass J,
McCarthy WJ, et al. Aortic diameter as a function of age, gender, and
body surface area. Surgery 1993;114:691-7.
45. Yau FS, Rosero EB, Clagett GP, Valentine RJ, Modrall GJ, Arko FR, et
al. Surveillance of small aortic aneurysms does not alter anatomic
suitability for endovascular repair. J Vasc Surg 2007;45:96-100.
46. Wever JJ, Blankensteijn JD, van Rijn JC, Broeders IA, Eikelboom BC,
Mali WP. Inter- and intraobserver variability of CT measurements
obtained after endovascular repair of abdominal aortic aneurysms. AJR
Am J Roentgenol 2000;175:1279-82.
47. Sampaio SM, Panneton JM, Mozes G, Andrews JC, Noel AA, Kalra M,
et al. AneuRx device migration: incidence, risk factors, and conse-
quences. Ann Vasc Surg 2005;19:178-85.
48. Conners MS 3rd, Sternbergh WC 3rd, Carter G, Tonnessen BH,
Yoselevitz M, et al. Endograft migration one to four years after endo-
vascular abdominal aortic aneurysm repair with the AneuRx device: a
cautionary note. J Vasc Surg 2002;36:476-84.
49. Jones KG, Brull DJ, Brown LC, Sian M, Greenhalgh RM, Humphries
SE, et al. Interleukin-6 (IL-6) and the prognosis of abdominal aortic
aneurysms. Circulation 2001;103:2260-5.
50. Vainas T, Lubbers T, Stassen FR, Herngreen SB, van Dieijen-Visser
MP, Bruggeman CA, et al. Serum C-reactive protein level is associated
with abdominal aortic aneurysm size and may be produced by aneurys-
mal tissue. Circulation 2003;107:1103-5.
51. Rohde LE, Arroyo LH, Rifai N, CreagerMA, Libby P, Ridker PM, et al.
Plasma concentrations of interleukin-6 and abdominal aortic diameter
among subjects without aortic dilatation. Arterioscler Thromb Vasc
Biol 1999;19:1695-9.
52. Norman P, Spencer CA, Lawrence-BrownMM, Jamrozik K. C-reactive
protein levels and the expansion of screen-detected abdominal aortic
aneurysms in men. Circulation 2004;110:862-6.
53. Choke E, Thompson MM, Dawson J, Wilson WR, Sayed S, Loftus IM,
et al. Abdominal aortic aneurysm rupture is associated with increased
medial neovascularization and overexpression of proangiogenic cyto-
kines. Arterioscler Thromb Vasc Biol 2006;26:2077-82.
54. WilsonWR, AndertonM, Schwalbe EC, Jones JL, Furness PN, Bell PR,
et al. Matrix metalloproteinase-8 and 9 are increased at the site of
abdominal aortic aneurysm rupture. Circulation 2006;113:438-45.
55. Cho JS, Gloviczki P, Martelli E, Harmsen WS, Landis ME, Cherry KJ
Jr, et al. Long-term survival and late complications after repair of
ruptured abdominal aortic aneurysms. J Vasc Surg 1998;27:813-9;
discussion 819-20.
56. Nyman U, Uher P, Lindh M, Lindblad B, Ivancev K. Primary stenting
in infrarenal aortic occlusive disease. Cardiovasc Intervent Radiol 2000;
23:97-108.
57. de Vries JP, van Den Heuvel DA, Vos JA, van Den Berg JC, Moll FI.
Freedom from secondary interventions to treat stenotic disease after
percutaneous transluminal angioplasty of infrarenal aorta: long-term
results. J Vasc Surg 2004;39:427-31.
58. Leurs LJ, Stultiens G, Kievit J, Buth J. Adverse events at the aneurysmal
neck identified at follow-up after endovascular abdominal aortic aneu-
rysm repair: how do they correlate? Vascular 2005;13:261-7.
59. Chaikof EL, Blankensteijn JD, Harris PL, White GH, Zarins CK,
Bernhard VM, et al. Reporting standards for endovascular aortic aneu-
rysm repair. J Vasc Surg 2002;35:1048-60.
60. Wever JJ, Blankensteijn JD, Mali TMWP, Eikelboom BC. Maximal
aneurysm diameter follow-up is inadequate after endovascular abdom-
inal aortic aneurysm repair. Eur J Vasc Endovasc Surg 2000;20:177-82.
JOURNAL OF VASCULAR SURGERY
April 2008892 Diehm et al61. Diehm N, Kickuth R, Gahl B, Do DD, Schmidli J, Rattunde H, et al.
Intraobserver and interobserver variability of 64-row computed tomog-
raphy abdominal aortic aneurysm neck measurements. J Vasc Surg
2007;45:263-8.
62. Lederle FA, Johnson GR, Wilson SE, et al. Prevalence and associations
of abdominal aortic aneurysm detected through screening. Aneurysm
Detection and Management (ADAM) Veterans Affairs Cooperative
Study Group. Ann Intern Med 1997;126:441-9.63. Singh K, Bonaa KH, Jacobsen BK, Bjork L, Solberg S. Prevalence of and
risk factors for abdominal aortic aneurysms in a population-based study:
the Tromso Study. Am J Epidemiol 2001;154:236-44.
64. Brady AR, Thompson SG, Fowkes FG, Greenhalgh RM, Powell JT.
Abdominal aortic aneurysm expansion: risk factors and time intervals for
surveillance. Circulation 2004;110:16-21.Submitted Jul 8, 2007; accepted Sep 13, 2007.
